Goldman Sachs Group Inc Standard Biotools Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Standard Biotools Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,319,084 shares of LAB stock, worth $1.69 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,319,084
Previous 676,529
94.98%
Holding current value
$1.69 Million
Previous $730,000
116.71%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding LAB
# of Institutions
166Shares Held
278MCall Options Held
34.9KPut Options Held
0-
Casdin Capital, LLC New York, NY76.1MShares$97.4 Million12.8% of portfolio
-
Viking Global Investors LP58.7MShares$75.1 Million0.22% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$27.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$21.7 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR10.1MShares$12.9 Million0.56% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $101M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...